One-Year Outcomes of Hydrus Microstent Combined With Cataract Surgery: Efficacy Across Glaucoma Severity Levels
The Hydrus Microstent lowered medication use across all glaucoma severities. Further studies with larger sample sizes are warranted to support these findings.
Authors
- Georges M. Durr (ORCID: https://orcid.org/0000-0002-0627-3662)
- Po Hsiang Yuan (ORCID: https://orcid.org/0000-0003-1009-7419)
- Andrea Dahoud
- Kenan Bachour (ORCID: https://orcid.org/0000-0003-0016-8658)
- Moncef Berkache (ORCID: https://orcid.org/0000-0001-8192-3373)
- Daniel R. Chow (ORCID: https://orcid.org/0000-0002-6931-6316)
Institutions
- University of British Columbia (CA)
- McGill University (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Journal of Glaucoma
- Published
- 2025-10-20
- DOI
- https://doi.org/10.1097/ijg.0000000000002663
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00